Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
about
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsImplications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing.Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significance.
P2860
Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mutational spectrum and risk s ...... on next-generation sequencing.
@en
Mutational spectrum and risk s ...... on next-generation sequencing.
@nl
type
label
Mutational spectrum and risk s ...... on next-generation sequencing.
@en
Mutational spectrum and risk s ...... on next-generation sequencing.
@nl
prefLabel
Mutational spectrum and risk s ...... on next-generation sequencing.
@en
Mutational spectrum and risk s ...... on next-generation sequencing.
@nl
P2093
P2860
P356
P1433
P1476
Mutational spectrum and risk s ...... on next-generation sequencing.
@en
P2093
Ailing Deng
Bianhong Wang
Chongjian Chen
Guangyuan Hou
Honghua Li
Junbin Liang
Liping Dou
P2860
P304
32065-32078
P356
10.18632/ONCOTARGET.7028
P407
P577
2016-01-27T00:00:00Z